Biobeat Secures $50 Million Series Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor
Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor Petah Tikva, Israel and Boca Raton, FL, December 30, 2025 – Biobeat Technologies, … Biobeat Secures $50 Million Series Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor

